Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus ramipril for renal hemodynamics in overweight or obese adults with essential hypertension
NL-OMON34045Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of aliskiren and ramipril in essential hypertension (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Renal hemodynamics and Blood pressure. Started Jan 2011; status: active, not recruiting.
02
Drugs
aliskirenramipril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NL-OMON34045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34045.